Skip to main content
OpenTrials

Clinical trial condition

De Novo or Transformed Indolent B-cell Lymphoma

Explore clinical trials studying De Novo or Transformed Indolent B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

De Novo or Transformed Indolent B-cell Lymphoma trial results

Active, Not Recruiting

Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas

NCT05583149

Conditions
Aggressive B-cell NHL, C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma, C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma, +27 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions